Article (Published version) (479 Kb) - 
Limited access to UNIGE
Highlights
More informations
Scientific Article
unige:86323 
 |
Antalgie chez les patients avec une atteinte hépatique |
|
| Authors | ||
| Published in | Revue médicale suisse. 2015, vol. 11, no. 480, p. 1380-1384 | |
| Abstract | The lack of clear recommendations makes optimal pain management difficult in patients with hepatic function impairment. This article reviews the evidence on commonly used analgesics (paracetamol, NSAIDs, opiates). Paracetamol can be safely used at low doses (2-3 grams per day) for a period not exceeding a few days. NSAIDs should be avoided because of their direct hepatic toxicity and an increased risk of life-threatening side-effects (hemorrhagic, renal). Glucuronoconjugated opiates should be preferred but all must be used carefully because of the risk of side effects. Dosage reduction and/or increased dose interval are often required. | |
| Keywords | Acetaminophen/therapeutic use — Analgesia/adverse effects/methods — Analgesics/administration & dosage/adverse effects — Analgesics, Opioid/therapeutic use — Anti-Inflammatory Agents, Non-Steroidal/therapeutic use — Humans — Liver Diseases/complications/metabolism — Pain/complications/drug therapy/metabolism — Pain Management/adverse effects/methods | |
| Identifiers | PMID: 26267943 | |
| Full text | ||
| Structures | ||
| Research group | Groupe Desmeules Jules (pharmacologie/toxicologie) (567) | |
| Citation (ISO format) | INNAURATO, Giovanni, PIGUET, Valérie, SIMONET, Martine Louis. Antalgie chez les patients avec une atteinte hépatique. In: Revue médicale suisse, 2015, vol. 11, n° 480, p. 1380-1384. https://archive-ouverte.unige.ch/unige:86323 |
134 hits 
0 download 
Contact an author
Update